Overexpression of the TGF-β antagonist Smad7 in endometrial cancer

Gynecologic Oncology

Volumn 96, Issue 2, 2005, Pages 368-373

  Dowdy, Sean C ^a   Mariani, Andrea ^a   Reinholz, Monica M ^b   Keeney, Gary L ^a   Spelsberg, Thomas C ^b   Podratz, Karl C ^a   Janknecht, Ralf ^b  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

Endometrial cancer; HER2 Neu; Ras; Smad7; TGF

Indexed keywords

BETA CATENIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; RNA; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD7 PROTEIN;

ADULT; AGED; ARTICLE; BENIGN TUMOR; CANCER GRADING; CANCER RECURRENCE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOMETRIUM CANCER; FEMALE; HUMAN; HUMAN TISSUE; HYSTERECTOMY; MEDICAL RECORD; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; RNA EXTRACTION; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

BETA CATENIN; CYTOSKELETAL PROTEINS; DNA-BINDING PROTEINS; ENDOMETRIAL NEOPLASMS; FEMALE; GENE EXPRESSION; HUMANS; MIDDLE AGED; PHOSPHORYLATION; RECEPTOR, ERBB-2; RNA, NEOPLASM; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD7 PROTEIN; TRANS-ACTIVATORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 12344337203     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2004.10.006     Document Type: Article

References (31)

1. E. Silverberg, and J. Lubera Cancer statistics C.A. Cancer J. Clin. 37 1987 2 19
2. A. Jemal, T. Murray, A. Samuels, A. Ghafoor, E. Ward, and M.J. Thun Cancer statistics, 2003 C.A. Cancer J. Clin. 53 2003 5 26
3. M.B. Datto, Y. Li, J.F. Panus, D.J. Howe, Y. Xiong, and X.F. Wang Transfowrming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism Proc. Natl. Acad. Sci. U. S. A. 92 1995 5545 5549
4. G.J. Hannon, and D. Beach p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest Nature 371 1994 257 261
5. J.A. Pietenpol, R.W. Stein, E. Moran, P. Yaciuk, R. Schlegel, and R.M. Lyons TGF-beta 1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains Cell 61 1990 777 785
6. J.A. Pietenpol, J.T. Holt, R.W. Stein, and H.L. Moses Transforming growth factor beta 1 suppression of c-myc gene transcription: role in inhibition of keratinocyte proliferation Proc. Natl. Acad. Sci. U. S. A. 87 1990 3758 3762
7. X. Liu, Y. Sun, R.A. Weinberg, and H.F. Lodish Ski/Sno and TGF-beta signaling Cytokine Growth Factor Rev. 12 2001 1 8
8. J. Massague How cells read TGF-beta signals Nat. Rev., Mol. Cell Biol. 1 2000 169 178
9. M.A. Lynch, R. Nakashima, H. Song, V.L. DeGroff, D. Wang, and T. Enomoto Mutational analysis of the transforming growth factor beta receptor type II gene in human ovarian carcinoma Cancer Res. 58 1998 4227 4232
10. S.J. Kim, Y.H. Im, S.D. Markowitz, and Y.J. Bang Molecular mechanisms of inactivation of TGF-beta receptors during carcinogenesis Cytokine Growth Factor Rev. 11 2000 159 168
11. T. Chen, J. Triplett, B. Dehner, B. Hurst, B. Colligan, and J. Pemberton Transforming growth factor-beta receptor type I gene is frequently mutated in ovarian carcinomas Cancer Res. 61 2001 4679 4682
12. G.J. Riggins, K.W. Kinzler, B. Vogelstein, and S. Thiagalingam Frequency of Smad gene mutations in human cancers Cancer Res. 57 1997 2578 2580
13. M. Afrakhte, A. Moren, S. Jossan, S. Itoh, K. Sampath, and B. Westermark Induction of inhibitory Smad6 and Smad7 mRNA by TGF-beta family members Biochem. Biophys. Res. Commun. 249 1998 505 511
14. A. Nakao, M. Afrakhte, A. Moren, T. Nakayama, J.L. Christian, and R. Heuchel Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling Nature 389 1997 631 635
15. H. Hayashi, S. Abdollah, Y. Qiu, J. Cai, Y.Y. Xu, and B.W. Grinnell The MAD-related protein Smad7 associates with the TGFbeta receptor and functions as an antagonist of TGFbeta signaling Cell 89 1997 1165 1173
16. T. Ebisawa, M. Fukuchi, G. Murakami, T. Chiba, K. Tanaka, and T. Imamura Smurf1 interacts with transforming growth factor-beta type I receptor through Smad7 and induces receptor degradation J. Biol. Chem. 276 2001 12477 12480 [Electronic publication 2001 Feb 13]
17. P. Kavsak, R.K. Rasmussen, and C.G. Causing Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation Mol. Cell 6 2000 1365 1375
18. R.P. Nagarajan, J. Zhang, W. Li, and Y. Chen Regulation of Smad7 promoter by direct association with Smad3 and Smad4 J. Biol. Chem. 274 1999 33412 33418
19. G. von Gersdorff, K. Susztak, F. Rezvani, M. Bitzer, D. Liang, and E.P. Bottinger Smad3 and Smad4 mediate transcriptional activation of the human Smad7 promoter by transforming growth factor beta J. Biol. Chem. 275 2000 11320 11326
20. S.C. Dowdy, A. Mariani, and R. Janknecht HER2/Neu- and TAK1-mediated up-regulation of the transforming growth factor beta inhibitor Smad7 via the ETS protein ER81 J. Biol. Chem. 278 2003 44377 44384 [Electronic publication 2003 Aug 28]
21. P.M. Holland, R.D. Abramson, R. Watson, and D.H. Gelfand Detection of specific polymerase chain reaction product by utilizing the 5′-3′ exonuclease activity of thermus aquaticus DNA polymerase Proc. Natl. Acad. Sci. U. S. A. 88 1991 7276 7280
22. C.A. Heid, J. Stevens, K.J. Livak, and P.M. Williams Real time quantitative PCR Genome Res. 6 1996 986 994
23. M.M. Reinholz, S.J. Iturria, J.N. Ingle, and P.C. Roche Differential gene expression of TGF-beta family members and osteopontin in breast tumor tissue: analysis by real-time quantitative PCR Breast Cancer Res. Treat. 74 2002 255 269
24. M.M. Reinholz, M.W. An, S.A. Johnsen, M. Subramaniam, V.J. Suman, and J.N. Ingle Differential gene expression of TGF-beta inducible early gene (TIEG), Smad7, Smad2 and Bard1 in normal and malignant breast tissue Breast Cancer Res. Treat. 166 2004 1 14
25. J.N. Topper, J. Cai, Y. Qiu, K.R. Anderson, Y.Y. Xu, and J.D. Deeds Vascular MADs: two novel MAD-related genes selectively inducible by flow in human vascular endothelium Proc. Natl. Acad. Sci. U. S. A. 94 1997 9314 9319
26. S. Dirnhofer, C. Berger, G. Untergasser, S. Geley, and P. Berger Human beta-actin retropseudogenes interfere with RT-PCR Trends Genet. 11 1995 380 381
27. T.V. Parekh, P. Gama, X. Wen, R. Demopoulos, J.S. Munger, and M.L. Carcangiu Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition Cancer Res. 62 2002 2778 2790
28. N. Mantel Evaluation of survival data and two new rank order statistics arising in its consideration Cancer Chemother. Rep. 50 1966 163 170
29. X. Liu, J. Lee, M. Cooley, E. Bhogte, S. Hartley, and A. Glick Smad7 but not Smad6 cooperates with oncogenic ras to cause malignant conversion in a mouse model for squamous cell carcinoma Cancer Res. 63 2003 7760 7768
30. J.L. Boulay, G. Mild, A. Lowy, J. Reuter, M. Lagrange, and L. Terracciano Smad7 is a prognostic marker in patients with colorectal cancer Int. J. Cancer 104 2003 446 449
31. T. Enomoto, M. Fujita, M. Inoue, J.M. Rice, R. Nakajima, and O. Tanizawa Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium Cancer Res. 53 1993 1883 1888